How can regular (L‑) epinephrine be converted to a racemic mixture?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Converting Regular (L-) Epinephrine to Racemic Epinephrine

If racemic epinephrine is not available, single-isomer L-epinephrine (1:1000) can be substituted at a dosage of 0.5 mL/kg up to 5 mL for laryngotracheobronchitis (croup) and acute airway edema. 1

Direct Substitution Protocol

You cannot chemically "convert" L-epinephrine to racemic epinephrine in clinical practice—racemization requires years of storage and results in degraded, inactive product 2. Instead, use L-epinephrine as a direct therapeutic substitute with appropriate dosing adjustments.

For Croup and Acute Airway Edema

Standard racemic epinephrine dosing:

  • 2.25% inhalation solution: 0.05 mL/kg (maximum: 0.5 mL) in 2 mL of normal saline administered by nebulizer 1
  • Many institutions use a standard 0.5-mL dose of racemic epinephrine for all patients 1

L-epinephrine (1:1000) substitution:

  • Use 0.5 mL/kg of 1:1000 solution (maximum: 5 mL = 5 mg) administered by nebulizer 1
  • This provides equivalent therapeutic effect for laryngotracheobronchitis and acute airway edema 1

Key Clinical Considerations

Why This Substitution Works

  • L-epinephrine is the active isomer responsible for the therapeutic effects 2
  • Racemic epinephrine contains 50% L-epinephrine (active) and 50% D-epinephrine (inactive) 2
  • The higher volume dosing of L-epinephrine (0.5 mL/kg vs 0.05 mL/kg) compensates for the lack of the inactive D-isomer while delivering equivalent active drug 1

Important Caveats

  • Do not attempt to create racemic epinephrine by aging L-epinephrine solutions—racemization takes approximately 4 years and results in significant oxidation and loss of potency (less than 90% active adrenaline after 4 years) 2
  • Ensure you are using the correct concentration: 1:1000 (1 mg/mL) for nebulized croup treatment, not 1:10,000 1
  • Always dilute in normal saline for nebulization 1

Dosing Safety

  • Maximum dose of L-epinephrine for croup: 5 mL (5 mg) 1
  • Administer via nebulizer over appropriate time period 1
  • Monitor for systemic effects including tachycardia, hypertension, and arrhythmias 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Racemization and oxidation in adrenaline injections.

Acta pharmaceutica Nordica, 1990

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.